Pharmaceutical supply chains are highly globalised and exposed to ESG risks including modern slavery in raw material extraction, emissions from chemical processing, biodiversity impacts and complex outsourced manufacturing models. ESG software provides a defensible and systematic way to quantify these risks across suppliers and jurisdictions, supporting regulatory obligations and internal governance.